P2Y Receptor Inhibitors

P2Y1 Receptor

P2Y2 Receptor

P2Y6 Receptor

P2Y12 Receptor

P2Y13 Receptor

P2Y14 Receptor

P2Y Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	P2Y1 Receptor	P2Y2 Receptor	P2Y6 Receptor	P2Y12 Receptor	P2Y13 Receptor	P2Y14 Receptor	Purity
Ticagrelor				P2Y12 Receptor			99.95%
Clopidogrel				P2Y12 Receptor			99.57%
Uridine 5′-diphosphoglucose disodium						P2Y14 Receptor	99.98%
P2Y14R antagonist 3						P2Y14 Receptor, IC₅₀: 23.6 nM P2Y14 Receptor, Kd: 7.26 μM
UDP-Galactose disodium						P2Y14 Receptor, EC₅₀: 0.67 μM	99.42%
Cangrelor tetrasodium				P2Y12 Receptor			99.96%
Diquafosol tetrasodium		P2Y2 Receptor					≥99.0%
MRS 2578			P2Y6 Receptor				98.15%
Uridine-5'-diphosphate disodium salt			P2Y6 Receptor				99.23%
YM-254890	P2Y1 Receptor						≥99.0%
AR-C118925XX		P2Y2 Receptor					≥99.0%
PSB-0739				P2Y12 Receptor			≥98.0%
Clopidogrel hydrogen sulfate				P2Y12 Receptor			99.88%
PPTN hydrochloride						P2Y14 Receptor	99.89%
2-MeS-ADP trisodium				P2Y12 Receptor	P2Y13 Receptor		99.90%
BPTU	P2Y1 Receptor						99.67%
Prasugrel				P2Y12 Receptor			99.85%
MRS2500 tetraammonium	P2Y1 Receptor						99.85%
Uridine 5′-diphosphoglucose (Standard)						P2Y14 Receptor
Prasugrel hydrochloride				P2Y12 Receptor			98.49%
2-Methylthio-AMP				P2Y12 Receptor			98.94%
PIT	P2Y1 Receptor, IC₅₀: 0.14 μM μM						99.07%
AZD1283				P2Y12 Receptor, IC₅₀: 11 nM			99.33%
Clopidogrel thiolactone				P2Y12 Receptor			≥98.0%
ADP-β-S trilithium				P2Y12 Receptor
P2Y6R antagonist 1			P2Y6 Receptor, IC₅₀: 19.6 nM				99.94%
Elinogrel				P2Y12 Receptor			98.68%
P2Y14R antagonist 2						P2Y14 Receptor, IC₅₀: 0.40 nM	99.56%
4-Thiouridine 5′-triphosphate tetralithium		P2Y2 Receptor, EC₅₀: 35 nM
MRS2768 tetrasodium salt		P2Y2 Receptor					98.70%
P2Y14R antagonist 1	P2Y1 Receptor, IC₅₀: > 100 nM	P2Y2 Receptor, IC₅₀: > 100 nM	P2Y6 Receptor, IC₅₀: 89.7 nM	P2Y12 Receptor, IC₅₀: > 100 nM		P2Y14 Receptor, IC₅₀: 0.6 nM	98.58%
MRS2365	P2Y1 Receptor, EC₅₀: 0.4 nM
Ticagrelor-d₇				P2Y12 Receptor
MRS2365 trisodium	P2Y1 Receptor, EC₅₀: 0.4 nM						≥99.0%
MRS2279 diammonium	P2Y1 Receptor, IC₅₀: 51.6 nM						≥98.0%
Prasugrel-d₃				P2Y12 Receptor			98.58%
2-Methylthio-AMP diTEA				P2Y12 Receptor			≥98.0%
Adenosine 2',5'-diphosphate sodium	P2Y1 Receptor						≥99.0%
Uridine 5′-diphosphoglucose						P2Y14 Receptor
Cangrelor				P2Y12 Receptor
SAR216471 hydrochloride				P2Y12 Receptor
P2Y1/P2Y6 antagonist 1	P2Y1 Receptor, IC₅₀: 9.72 μM		P2Y6 Receptor, IC₅₀: 1.89 μM
Uridine 5'-O-thiodiphosphate trisodium			P2Y6 Receptor, EC₅₀: 28 nM
HDL-16						P2Y14 Receptor, IC₅₀: 0.3095 nM	99.19%
UDP-Galactose						P2Y14 Receptor, EC₅₀: 0.67 μM
Diquafosol		P2Y2 Receptor
Regrelor disodium				P2Y12 Receptor
4-Thiouridine 5′-triphosphate tetrasodium		P2Y2 Receptor, EC₅₀: 35 nM
P2Y14R antagonist 4						P2Y14 Receptor, IC₅₀: 5.6 nM
P2Y14R antagonist 5						P2Y14 Receptor, IC₅₀: 23.60 nM
Prasugrel-d₅				P2Y12 Receptor
MRS-2179	P2Y1 Receptor
TNP-ATP tetrasodium	P2Y1 Receptor, IC₅₀: 6 nM
2-MeSADP				P2Y12 Receptor, EC₅₀: 5 nM	P2Y13 Receptor, EC₅₀: 19 nM
Blue FPG-A trisodium	P2Y1 Receptor, IC₅₀: 2.6 μM
MRS2693 ammonium			P2Y6 Receptor, EC₅₀: 0.015 μM
MRS2279	P2Y1 Receptor, IC₅₀: 51.6 nM
MRS4833						hP2Y14R, IC₅₀: 5.92 nM mP2Y14R, IC₅₀: 4.8 nM
5-OMe-UDP			P2Y6 Receptor, EC₅₀: 0.08 μM
Uridine 5′-diphosphoglucose-¹³C disodium			P2Y6 Receptor
MRS2496	P2Y1 Receptor
P2Y1 antagonist 1	P2Y1 Receptor
Sp-UTP-α-S		P2Y2 Receptor
MRS2905 trisodium						P2Y14 Receptor, EC₅₀: 0.92 nM
Prasugrel (Maleic acid)				P2Y12 Receptor
UDP-GlcNAc						P2Y14 Receptor
MRS2603	P2Y1 Receptor				P2Y13 Receptor
Elinogrel potassium				P2Y12 Receptor
(Rac)-BX 048				P2Y12 Receptor
2-Thio-UTP		P2Y2 Receptor, EC₅₀: 50 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4